These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
255 related articles for article (PubMed ID: 7737632)
1. Serum cholestanol, cholesterol precursors, and plant sterols during placebo-controlled treatment of primary biliary cirrhosis with ursodeoxycholic acid or colchicine. Miettinen TA; Färkkilä M; Vuoristo M; Karvonen AL; Leino R; Lehtola J; Friman C; Seppälä K; Tuominen J Hepatology; 1995 May; 21(5):1261-8. PubMed ID: 7737632 [TBL] [Abstract][Full Text] [Related]
2. High cholestanol and low campesterol-to-sitosterol ratio in serum of patients with primary biliary cirrhosis before liver transplantation. Nikkilä K; Höckerstedt K; Miettinen TA Hepatology; 1991 Apr; 13(4):663-9. PubMed ID: 2010161 [TBL] [Abstract][Full Text] [Related]
3. [Combined ursodeoxycholic acid plus colchicine--treatment of primary biliary cirrhosis: results of a placebo-controlled double-blind study]. Raedsch R; Stiehl A; Walker S; Scherrmann JM; Kommerell B Z Gastroenterol; 1992 Mar; 30 Suppl 1():55-7. PubMed ID: 1449019 [TBL] [Abstract][Full Text] [Related]
4. Sterol parameters as markers of liver function in primary biliary cirrhosis before and after liver transplantation. Nikkilä K; Miettinen TA; Höckerstedt KV; Isoniemi H Transpl Int; 2005 Feb; 18(2):221-5. PubMed ID: 15691276 [TBL] [Abstract][Full Text] [Related]
5. Serum cholesterol precursors, cholestanol, and plant sterols in primary biliary cirrhosis. Nikkilä K; Miettinen TA Scand J Gastroenterol; 1988 Oct; 23(8):967-72. PubMed ID: 3201135 [TBL] [Abstract][Full Text] [Related]
6. Serum sterols in patients with primary biliary cirrhosis and acute liver failure before and after liver transplantation. Nikkilä K; Nissinen MJ; Gylling H; Isoniemi H; Miettinen TA J Hepatol; 2008 Dec; 49(6):936-45. PubMed ID: 18926587 [TBL] [Abstract][Full Text] [Related]
7. A randomized trial comparing colchicine and ursodeoxycholic acid combination to ursodeoxycholic acid in primary biliary cirrhosis. UDCA-PBC Study Group. Poupon RE; Huet PM; Poupon R; Bonnand AM; Nhieu JT; Zafrani ES Hepatology; 1996 Nov; 24(5):1098-103. PubMed ID: 8903382 [TBL] [Abstract][Full Text] [Related]
8. Twenty-one year tracking of serum non-cholesterol sterols. The Cardiovascular Risk in Young Finns study. Miettinen TA; Hallikainen M; Raitakari OT; Viikari J; Gylling H Nutr Metab Cardiovasc Dis; 2009 Oct; 19(8):525-31. PubMed ID: 19185477 [TBL] [Abstract][Full Text] [Related]
11. Cholesterol metabolism and serum and biliary noncholesterol sterols in gallstone patients during simvastatin and ursodeoxycholic acid treatments. Miettinen TE; Kiviluoto T; Taavitsainen M; Vuoristo M; Miettinen TA Hepatology; 1998 Mar; 27(3):649-55. PubMed ID: 9500689 [TBL] [Abstract][Full Text] [Related]
12. Applicability of non-cholesterol sterols in predicting response in cholesterol metabolism to simvastatin and fluvastatin treatment among hypercholesterolemic men. Nissinen MJ; Miettinen TE; Gylling H; Miettinen TA Nutr Metab Cardiovasc Dis; 2010 Jun; 20(5):308-16. PubMed ID: 19695854 [TBL] [Abstract][Full Text] [Related]
14. A prospective trial of colchicine for primary biliary cirrhosis. Kaplan MM; Alling DW; Zimmerman HJ; Wolfe HJ; Sepersky RA; Hirsch GS; Elta GH; Glick KA; Eagen KA N Engl J Med; 1986 Dec; 315(23):1448-54. PubMed ID: 3537784 [TBL] [Abstract][Full Text] [Related]
15. A randomized, double-blind, placebo-controlled trial of ursodeoxycholic acid in primary biliary cirrhosis. Combes B; Carithers RL; Maddrey WC; Lin D; McDonald MF; Wheeler DE; Eigenbrodt EH; Muñoz SJ; Rubin R; Garcia-Tsao G Hepatology; 1995 Sep; 22(3):759-66. PubMed ID: 7657280 [TBL] [Abstract][Full Text] [Related]
16. A placebo-controlled trial of primary biliary cirrhosis treatment with colchicine and ursodeoxycholic acid. Vuoristo M; Färkkilä M; Karvonen AL; Leino R; Lehtola J; Mäkinen J; Mattila J; Friman C; Seppälä K; Tuominen J Gastroenterology; 1995 May; 108(5):1470-8. PubMed ID: 7729640 [TBL] [Abstract][Full Text] [Related]
17. Serological markers for monitoring disease progression in noncirrhotic primary biliary cirrhosis on ursodeoxycholic acid therapy. Färkkilä M; Rautiainen H; Kärkkäinen P; Karvonen AL; Nurmi H; Niemelä O Liver Int; 2008 Jul; 28(6):787-97. PubMed ID: 18397236 [TBL] [Abstract][Full Text] [Related]
18. A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. UDCA-PBC Study Group. Poupon RE; Balkau B; Eschwège E; Poupon R N Engl J Med; 1991 May; 324(22):1548-54. PubMed ID: 1674105 [TBL] [Abstract][Full Text] [Related]
19. Synthesis of interleukin-1 beta in primary biliary cirrhosis: relationship to treatment with methotrexate or colchicine and disease progression. Miller LC; Sharma A; McKusick AF; Tassoni JP; Dinarello CA; Kaplan MM Hepatology; 1995 Aug; 22(2):518-24. PubMed ID: 7635420 [TBL] [Abstract][Full Text] [Related]
20. Improved prognosis of patients with primary biliary cirrhosis that have a biochemical response to ursodeoxycholic acid. Kuiper EM; Hansen BE; de Vries RA; den Ouden-Muller JW; van Ditzhuijsen TJ; Haagsma EB; Houben MH; Witteman BJ; van Erpecum KJ; van Buuren HR; Gastroenterology; 2009 Apr; 136(4):1281-7. PubMed ID: 19208346 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]